IONS vs SKYE · rev $226.6M vs $25.0M cap
Ionis Pharmaceuticals Inc (IONS) versus Skye Bioscience, Inc. Common Stock (SKYE) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
SKYE does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. SKYE currently screens at market cap $25.0M.
Not investment advice. Open the IONS and SKYE stock pages for the full models.
Not investment advice.